Home / Gemfibrozil / United States
US ATC C10AB04 · updated 2 Nov 2026
Gemfibrozil shortage in United States
Is there a Gemfibrozil shortage in United States?
Yes. As of 2 Nov 2026, 1 Gemfibrozil product is reported short in United States, the first since 10 Feb 2026. No return date has been given. Main reason: not stated.
Also short in Italy. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lopid, Tablet, 600 mg (NDC 0071-0737-20) discontinuation | Pfizer Inc. | 10 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).